Randomized controlled trials (RCTs) are conducted under idealized and rigorously
controlled conditions that may compromise their external validity. A literature review was …

Background Specialised disease management programmes for heart failure aim to improve
care, clinical outcomes and/or reduce healthcare utilisation. Since the last version of this …

Background Atrial fibrillation and heart failure often coexist, causing substantial
cardiovascular morbidity and mortality. β blockers are indicated in patients with symptomatic …

Aims Co‐morbidities frequently accompany heart failure (HF), contributing to increased
morbidity and mortality, and an impairment of quality of life. We assessed the prevalence …

Aims To assess physicians' adherence to guideline‐recommended medications for the
treatment of chronic heart failure (CHF) with reduced ejection fraction. Methods and results …

Aims The objective of the EuroHeart Failure Survey II (EHFS II) was to assess patient
characteristics, aetiology, treatment, and outcome of acute heart failure (AHF) in Europe in …

Background: Heart failure (HF) is one of the leading causes of hospitalization in adults in
Brazil. However, most of the available data is limited to unicenter registries. The BREATHE …

Aims Natriuretic peptide-guided (NP-guided) treatment of heart failure has been tested
against standard clinically guided care in multiple studies, but findings have been limited by …

Aims Hyperkalaemia in heart failure patients limits use of cardioprotective renin–angiotensin–
aldosterone system inhibitors (RAASi). Sodium zirconium cyclosilicate (ZS‐9) is a selective …

The natriuretic peptides are important tools to establish diagnosis and prognosis in heart
failure (HF). With application of therapies for HF, changes in both B-type natriuretic peptide …